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An 82-year-old man who had undergone transurethral resection (TUR) for superficial bladder cancer
(pT1 G3) in June and Luly 2011 received intravesical Bacillus Calmette-Guerin therapy (80 mg weekly for 6
weeks) in September 2011. Seven months later, a follow-up cystoscopy revealed a slowly growing torose
lesion at the site of the previous TUR. The lesion was removed by TUR in June 2012. Pathological
examination showed an inflammatory response with small granulomatous lesions. The specimen stained
positive for TB DNA-RTPCR. Mycobacterium bovis was detected from the bladder specimen and urine.
He was administered antituberculous agents, isoniazid 300 mg and rifampicin 450 mg daily, for 3 months.
He is well with no recurrence of bladder carcinoma and urinary cultures were negative during the follow-up.
(Hinyokika Kiyo 59 : 457-460, 2013)
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患者 : 82歳 男性
既往歴 : 特記すべきことなし
身体所見 : 特記すべきことなし
入院時検査所見（2012/6) : 血液一般 : WBC 8,
100/μl，RBC 428×104/μl，Hb 13.4 g/dl，PLT 35.2×
104/μl，Na 141 mEq/l，K 3.8 mEq/l，Cl 104 mEq/l，
BUN 15 mg/dl，Cre 0.87 mg/dl，CRP 0.78 mg/dl
尿沈渣 : RBC 5∼9/1，WBC ＜1/1，扁平上皮細胞
＜1/1
現病歴 : 2011年 4月肉眼的血尿あり近医受診．尿細
胞診 class IIIa のため当科紹介となった．外来で施行
した膀胱鏡では右側壁に 3 cm 大の乳頭状腫瘍を認め
た (Fig. 1）．同年 6 月に経尿道的膀胱腫瘍切除術
泌59,07,12-1
Fig. 1. Cystoscopy revealed a papillary tumor at the
right bladder wall.
(TURBT) を施行．病理結果はUCG3 pT1 であった．
病理結果より同年 7 月に 2ndTUR を施行．病理結果
は筋層浸潤なく悪性所見なしであった．その後 BCG
（イムシスト○R コンノート株）81 mg を週 1回の割合





て右側壁 TUR 跡に粘膜の隆起を認めた (Fig. 2）．尿
細胞診は class IIIa ，尿 TB-DNA PCR は陰性であっ




Fig. 2. A : Focal urinary bladder lesion one month
after intravesical BCG treatment. B : Three
months after BCG treatment, cystoscopy
showed no tumor recurrence and the blad-
der wall is flat. C : Six months after BCG
treatment, cystoscopy detected a torose le-





TUR 検体の TB-DNA PCR が陽性，TUR 検体の抗酸
菌培養も陽性であった．術前に採取した尿の抗酸菌培
養も陽性であった．以上より膀胱結核の診断のもと
に，isoniacid (INH) 300 ml/日・rifampicin (RFP) 450
mg/日内服開始．抗酸菌同定試験では，抗酸菌培養で
泌59,07,12-3
Fig. 3. Section of a bladder lesion from TUR speci-
men shows granulomatous and inflam-
matory cell. Hematoxylin and eosin. Ori-
ginal magnification ×100.
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